Cantitate/Preț
Produs
Total produse
Vezi coșul
Privileged Scaffolds in Drug Discovery de Bin Yu

Privileged Scaffolds in Drug Discovery

Editat de Bin Yu, Ning Li, Caiyun Fu
en Limba Engleză Paperback – 19 iul 2023
Privileged Scaffolds in Drug Discovery is the most complete and up-to-date work in the area. Covering a wide range of privileged structures, it is a perfect reference for scientists involved in targeted drug development.
The editors recruited experts from several prestigious Chinese institutions to cover the areas of antiviral drugs, chalcone, pyrimidine, (benz)imidazoles, natural product-derived privileged scaffolds, N-Sulfonyl carboxamides, kinase inhibitors, antitumor molecules, antineurodegenerative drugs, triazoles, oxazolidinone, indole and indoline scaffolds, tigliane diterpenoids, peptide and peptide-based drugs, quassinoids, and others including pseudonatural products, macrocycles, stable peptides and peptidomimetics. The book also explores scaffolds in drug molecules approved in recent years.
Privileged Scaffolds in Drug Discovery is a complete reference for researchers in drug discovery and organic synthesis, in academic and corporate settings, who are investigating privileged structures upon which to base new drugs. Researchers in medicinal chemistry and chemical biology will also find the contents of this book valuable.


  • Provides wide coverage of privileged scaffolds in new drug discovery
  • Includes complex and diverse natural product scaffolds
  • Covers applications to peptides and peptide-based drugs
Citește tot Restrânge

Preț: 126393 lei

Preț vechi: 157709 lei
-20% Nou

Puncte Express: 1896
Preț estimativ în valută:
24189€ • 25516$ • 20216£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443186110
ISBN-10: 0443186111
Pagini: 986
Dimensiuni: 216 x 276 mm
Editura: ELSEVIER SCIENCE

Public țintă

Researchers in Drug Discovery, and Organic Synthesis.

Cuprins

1. Thiazole, a privileged scaffold in new drug discovery 2. Chalcone: Diverse biological activities and structure-activity relationships 3. Privileged chalcone scaffolds in drug discovery 4. The N-sulfonyl carboxamide moiety as a privileged structure in approved drugs 5. Scaffolds in cytotoxic drugs and novel antitumor molecules interacting with nucleic acids 6. Triazoles: a privileged scaffold in drug design and novel drug discovery 7. Oxazolidinone scaffolds in drug discovery and development 8. Indole and indoline scaffolds in drug discovery 9. Cyanopyridine as a privileged scaffold in drug discovery 10. Indazole as privileged scaffold in drug discovery 11. (Benz)imidazoles: privileged scaffolds in medicinal chemistry 12. Tranylcypromine (TCP): a privileged scaffold for designing histone lysine demethylase 1 inhibitors 13. Applications of piperazine scaffold in drug design 14. Thiols as a privileged scaffold against metallo-ß-lactamases 15. Tetrahydro-ß-carboline scaffold in drug discovery 16. Benzoxaborole: a privileged scaffold for drug discovery 17. Privileged scaffolds in anti-diabetic drug discovery 18. Authentic HIV-1 integrase inhibitors for the treatment of HIV-1/AIDS 19. 2-Aminopyrimidine: a privileged scaffold in kinase drug discovery 20. Alzheimer’s disease therapeutics: current strategies and future directions 21. Sulfonyl fluorides as warheads in drug discovery 22. a,ß-Bifunctionalized carbonyl compounds as privileged motifs in drug discovery and their synthetic protocols 23. Diarylpyrimidines and related analogs as antiviral agents 24. Organic synthetic methodology-based new scaffold in drug discovery 25. Natural resource of anti-human immunodeficiency virus leading compounds: tigliane diterpenoids 26. Biological phenethyl glycosides from plants 27. Triterpenoids and saponins in drug discovery 28. Casbene-derived diterpenoids 29. Quassinoids: phytochemistry and antitumor prospect 30. Structural diversity, biosynthesis, and biological functions of meroterpenoids from microbial metabolites 31. Glucocorticoid compounds in drug discovery by targeting glucocorticoid receptor protein 32. Peptide and peptide-based drugs 33. Stapled peptides for new drug discovery 34. Current status and trends in research and development of polypeptide drugs 35. Unique opportunities of metal scaffolds in drug design 36. N-Heterocyclic carbene as privileged scaffold in medicinal inorganic chemistry 37. Selenium-containing heterocycles 38. Computational methods for scaffold hopping